Windtree Therapeutics, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Windtree Therapeutics, Inc.
Elucid has developed machine learning models that can interpret a patient’s risk of stroke or cardiovascular events from angiography images.
Chinese biotechs listed in the US have a watershed day, with many shares nosediving by over 10% amid leadership changes in China, where the retirement of several economic pragmatists appears to be adding to souring investment sentiment amid views on rising uncertainties and risks.
Investigational products from Minoryx and a host of other companies targeting a range of diseases are now under review by the European Medicines Agency for potential EU approval.
A clutch of Chinese biopharma firms, including I-Mab, Lepu and Clover, are having second thoughts on some of their clinical development programs to conserve cash amid a funding squeeze.
- Medical Devices
- Drug Delivery
- Large Molecule
Drug Discovery Tools
- Other Names / Subsidiaries
- Discovery Labs